Thurston, Springer, Miller, Herd & Titak, Inc. Guardant Health, Inc. Transaction History
Thurston, Springer, Miller, Herd & Titak, Inc.
- $730 Million
- Q2 2025
A detailed history of Thurston, Springer, Miller, Herd & Titak, Inc. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Thurston, Springer, Miller, Herd & Titak, Inc. holds 898 shares of GH stock, worth $45,833. This represents 0.01% of its overall portfolio holdings.
Number of Shares
898
Previous 1,084
17.16%
Holding current value
$45,833
Previous $46,000
-0.0%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding GH
# of Institutions
392Shares Held
121MCall Options Held
1.43MPut Options Held
2.37M-
Vanguard Group Inc Valley Forge, PA12.1MShares$617 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$574 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.44MShares$278 Million8.11% of portfolio
-
Capital International Investors Los Angeles, CA5.15MShares$263 Million0.04% of portfolio
-
Baillie Gifford & CO5.06MShares$258 Million0.19% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $5.22B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...